Amivantamab with chemotherapy - Non-small cell lung cancer with EGFR exon 20 insertions

被引：0
|
作者：
Drappier, Noemie [1 ]
Pierret, Thomas [2 ]
机构：
[1] Univ Montpellier, Fac Med, F-34090 Montpellier, France
[2] Hosp Civils Lyon, Hop Louis Pradel, Serv Hosp Univ Pneumol, F-69500 Bron, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 12期
关键词：
Non-small cell lung cancer; EGFR exon 20 insertions; Amivantamab; Chemotherapy;
D O I：
10.1016/j.bulcan.2024.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1085 / 1087
页数：3
相关论文
共 50 条
  • [1] Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer
    Brazel, Danielle
    Nagasaka, Misako
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 133 - 138
  • [2] Amivantamab for the treatment of EGFR exon 20 insertion mutant non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (01) : 3 - 16
  • [3] Targeting EGFR Exon 20 Insertion Mutation in Non-small cell Lung Cancer: Amivantamab and Mobocertinib
    Russell, Molly C.
    Garelli, Alyssa M.
    Reeves, David J.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (02) : 198 - 206
  • [4] Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
    Zhou, Caicun
    Tang, Ke-Jing
    Cho, Byoung Chul
    Liu, Baogang
    Paz-Ares, Luis
    Cheng, Susanna
    Kitazono, Satoru
    Thiagarajan, Muthukkumaran
    Goldman, Jonathan W.
    Sabari, Joshua K.
    Sanborn, Rachel E.
    Mansfield, Aaron S.
    Hung, Jen-Yu
    Boyer, Michael
    Popat, Sanjay
    Mourao Dias, Josiane
    Felip, Enriqueta
    Majem, Margarita
    Gumus, Mahmut
    Kim, Sang-we
    Ono, Akira
    Xie, John
    Bhattacharya, Archan
    Agrawal, Trishala
    Shreeve, S. Martin
    Knoblauch, Roland E.
    Park, Keunchil
    Girard, Nicolas
    PAPILLON Investigators
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (22): : 2039 - 2051
  • [5] Amivantamab in Post-platinum EGFR Exon 20 Insertion Mutant Non-small Cell Lung Cancer
    Sabari, J. K.
    Shu, C. A.
    Park, K.
    Leighl, N.
    Mitchell, P.
    Kim, S.
    Lee, J.
    Kim, D.
    Viteri, S.
    Spira, A.
    Han, J.
    Trigo, J.
    Lee, C. K.
    Lee, K. H.
    Girard, N.
    Yang, T.
    Goto, K.
    Sanborn, R. E.
    Yang, J. C.
    Xie, J.
    Roshak, A.
    Thayu, M.
    Knoblauch, R. E.
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S108 - S109
  • [6] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
    Morita, Chie
    Yoshida, Tatsuya
    Shirasawa, Masayuki
    Masuda, Ken
    Matsumoto, Yuji
    Shinno, Yuki
    Yagishita, Shigehiro
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Motoi, Noriko
    Yatabe, Yasushi
    Ohe, Yuichiro
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Landscape and clinical implications of EGFR exon 20 insertions in non-small cell lung cancer patients
    Garzon-Ibanez, Monica
    Reyes, Roxana
    Molina-Vila, Miguel Angel
    Sullivan, Ivana Gabriela
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [8] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
    Chie Morita
    Tatsuya Yoshida
    Masayuki Shirasawa
    Ken Masuda
    Yuji Matsumoto
    Yuki Shinno
    Shigehiro Yagishita
    Yusuke Okuma
    Yasushi Goto
    Hidehito Horinouchi
    Noboru Yamamoto
    Noriko Motoi
    Yasushi Yatabe
    Yuichiro Ohe
    Scientific Reports, 11
  • [9] EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history begins
    Remon, Jordi
    Hendriks, Lizza E. L.
    Cardona, Andres F.
    Besse, Benjamin
    CANCER TREATMENT REVIEWS, 2020, 90
  • [10] Amivantamab: a monoclonal EGFR-MET bispecific antibody for EGFR exon 20 insertion in non-small cell lung cancer
    Xie, Yuhao
    Lu, Qisi
    Wang, Jing-Quan
    Bo, Letao
    Ashby, Charles R., Jr.
    Chen, Zhe-Sheng
    DRUGS OF TODAY, 2022, 58 (08) : 389 - 398
12345